Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

$CNC
Medical Specialities
Health Care
Get the next $CNC alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greco Thomas

(Last) (First) (Middle)
7700 FORSYTH BOULEVARD

(Street)
ST. LOUIS MO 63105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CENTENE CORP [ CNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/18/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/18/2024 P 17,000 A $59.75(1) 19,309(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The weighted average price for this transaction is reported within the form. Shares were purchased at prices ranging from $59.68 to $59.76. Full information regarding the number of shares at each price is available upon request.
2. Ownership includes 2,309 shares of restricted stock units subject to vesting requirements.
Remarks:
/s/ Christopher A. Koster (executed by attorney-in-fact) 12/19/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $CNC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CNC

DatePrice TargetRatingAnalyst
4/8/2025$64.00Underperform → Hold
Jefferies
2/6/2025Buy → Hold
Argus
12/17/2024$80.00 → $75.00Overweight
Analyst
12/13/2024$79.00 → $80.00Neutral → Buy
UBS
12/10/2024$68.00 → $52.00Hold → Underperform
Jefferies
7/24/2024$83.00 → $69.00Buy → Hold
Jefferies
5/30/2024$83.00Neutral
Robert W. Baird
3/21/2024$92.00 → $85.00Overweight → Equal-Weight
Stephens
More analyst ratings

$CNC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Health Net and Centene Foundation Commit $1 Million to Rebuild Los Angeles After Historic Fire Devastation

    Health Net to host convening with California Community Foundation and others to coordinate recovery of critical healthcare infrastructure SACRAMENTO, Calif., April 17, 2025 /PRNewswire/ -- One hundred days after the devastating Eaton Fire began, Health Net, one of California's most experienced Medi-Cal managed care health plans, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), announced an additional commitment of $750,000 for wildfire recovery efforts in Los Angeles County. This new funding brings Health Net and the Centene Foundation's total contribution to $1 million, underscoring their continued commitment to rebuilding and restoring impacted communiti

    $CNC
    Medical Specialities
    Health Care
  • CENTENE SUBSIDIARY SILVERSUMMIT HEALTHPLAN AWARDED NEVADA MEDICAID CONTRACT

    ST. LOUIS, April 10, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Nevada subsidiary, SilverSummit Healthplan, Inc. (SilverSummit), has been selected by the Nevada Department of Health and Human Services to provide services for its Medicaid managed care program. For the first time the program will include expansion of Medicaid Managed Care into rural and frontier service areas, communities that were previously fee-for-service. Subject to state approval, the five-year contract is expected to begin January 1, 2026, with a possible two-year extension. 

    $CNC
    Medical Specialities
    Health Care
  • Health Net and Centene Foundation Invest More than $9 Million in Initiatives to Expand and Strengthen California's Physician Workforce

    Investments will help address barriers to medical school, from youth through college, and support the development of today's practicing physicians SACRAMENTO, Calif., April 10, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), today announced a partnership investment of more than $9 million to help bolster the future of California's physician workforce in collaboration with multiple not-for-profit organizations. The funding aims to address the state's physician workforce shortage, specifically to engage Californians at critical milestones starting in ch

    $CNC
    Medical Specialities
    Health Care

$CNC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CNC
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$CNC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CNC
SEC Filings

See more

$CNC
Leadership Updates

Live Leadership Updates

See more
  • CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    $CNC
    Medical Specialities
    Health Care
  • Centene Corporation Names First President over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business

    New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan

    $CNC
    Medical Specialities
    Health Care
  • Sunshine Health Announces the Appointment of Charlene Zein as President and CEO

    PEMBROKE PINES, Fla., Nov. 7, 2024  /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi

    $CNC
    Medical Specialities
    Health Care

$CNC
Financials

Live finance-specific insights

See more
  • CENTENE CORPORATION TO HOST 2025 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors

    $CNC
    Medical Specialities
    Health Care
  • CENTENE CORPORATION REPORTS 2024 RESULTS

    -- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December

    $CNC
    Medical Specialities
    Health Care
  • CENTENE CORPORATION TO HOST 2024 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde

    $CNC
    Medical Specialities
    Health Care

$CNC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more